• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Concerns About the Timing and Settings of Initiating Extracorporeal Membrane Oxygenation in Patients With Severe Coronavirus Disease 2019 Pneumonia.

作者信息

Uemura Tatsuki, Matsuda Wataru, Ogawa Tatsunori

机构信息

Department of Emergency Medicine and Critical Care, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan, and ECMO Team, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

Department of Clinical Engineering, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan, and ECMO Team, Center Hospital of the National Center for Global Health and Medicine, Tokyo, Japan.

出版信息

Crit Care Med. 2020 Dec;48(12):e1357-e1358. doi: 10.1097/CCM.0000000000004560.

DOI:10.1097/CCM.0000000000004560
PMID:32804794
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7437423/
Abstract
摘要

相似文献

1
Concerns About the Timing and Settings of Initiating Extracorporeal Membrane Oxygenation in Patients With Severe Coronavirus Disease 2019 Pneumonia.关于重症2019冠状病毒病肺炎患者开始体外膜肺氧合的时机和设置的担忧
Crit Care Med. 2020 Dec;48(12):e1357-e1358. doi: 10.1097/CCM.0000000000004560.
2
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.体外膜肺氧合治疗 2019 冠状病毒病所致急性呼吸窘迫综合征：一项多中心描述性研究。
Crit Care Med. 2020 Sep;48(9):1289-1295. doi: 10.1097/CCM.0000000000004447.
3
Extracorporeal membrane oxygenation for acute respiratory distress syndrome in patients with coronavirus disease 2019: what do we know so far?2019冠状病毒病患者急性呼吸窘迫综合征的体外膜肺氧合：我们目前了解多少？
Perfusion. 2020 Sep;35(6):558-561. doi: 10.1177/0267659120934279. Epub 2020 Jun 24.
4
Ethics and extracorporeal membrane oxygenation during coronavirus disease 2019 outbreak.2019冠状病毒病疫情期间的伦理与体外膜肺氧合
Perfusion. 2020 Sep;35(6):562-564. doi: 10.1177/0267659120937545. Epub 2020 Jun 25.
5
[Study on the extracorporeal membrane oxygenation inter-hospital transport during coronavirus disease 2019 epidemic: based on the transport experience of 6 cases of severe H1N1 influenza virus pneumonia on extracorporeal membrane oxygenation].新型冠状病毒肺炎疫情期间体外膜肺氧合院际转运的研究：基于6例体外膜肺氧合治疗的重症甲型H1N1流感病毒肺炎患者的转运经验
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):430-434. doi: 10.3760/cma.j.cn121430-20200309-00413.
6
Acute Respiratory Distress Syndrome Treated With Awake Extracorporeal Membrane Oxygenation in a Patient With COVID-19 Pneumonia.清醒体外膜肺氧合治疗新型冠状病毒肺炎所致急性呼吸窘迫综合征1例
J Cardiothorac Vasc Anesth. 2021 Aug;35(8):2467-2470. doi: 10.1053/j.jvca.2020.11.017. Epub 2020 Nov 10.
7
Reply to Wengenmayer : Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19-related Acute Respiratory Distress Syndrome: Worth the Effort!回复温根迈尔：体外膜肺氧合用于治疗 COVID-19 相关急性呼吸窘迫综合征的重症患者：值得一试！
Am J Respir Crit Care Med. 2020 Nov 15;202(10):1479-1480. doi: 10.1164/rccm.202007-2670LE.
8
Treatment for severe acute respiratory distress syndrome from COVID-19.新型冠状病毒肺炎所致严重急性呼吸窘迫综合征的治疗
Lancet Respir Med. 2020 May;8(5):433-434. doi: 10.1016/S2213-2600(20)30127-2. Epub 2020 Mar 20.
9
Optimal therapeutic strategy using extracorporeal membrane oxygenation in patients with COVID-19.新型冠状病毒肺炎患者使用体外膜肺氧合的最佳治疗策略
J Card Surg. 2020 Oct;35(10):2872-2873. doi: 10.1111/jocs.14831.
10
Extracorporeal Membrane Oxygenation (ECMO) in Critically Ill Patients with Coronavirus Disease 2019 (COVID-19) Pneumonia and Acute Respiratory Distress Syndrome (ARDS).体外膜肺氧合（ECMO）在 2019 冠状病毒病（COVID-19）肺炎和急性呼吸窘迫综合征（ARDS）危重症患者中的应用。
Med Sci Monit. 2020 Aug 6;26:e925364. doi: 10.12659/MSM.925364.

引用本文的文献

1
Early Initiation of Venovenous Extracorporeal Membrane Oxygenation for Critically Ill COVID-19 Patients.危重新冠肺炎患者早期开始静脉-静脉体外膜肺氧合。
J Extra Corpor Technol. 2022 Mar;54(1):79-82. doi: 10.1182/ject-79-82.
2
Outcomes after extracorporeal membrane oxygenation support in COVID-19 and non-COVID-19 patients.COVID-19 与非 COVID-19 患者体外膜肺氧合支持后的结局。
Artif Organs. 2022 Apr;46(4):688-696. doi: 10.1111/aor.14090. Epub 2021 Nov 4.

本文引用的文献

1
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019-Induced Acute Respiratory Distress Syndrome: A Multicenter Descriptive Study.体外膜肺氧合治疗 2019 冠状病毒病所致急性呼吸窘迫综合征：一项多中心描述性研究。
Crit Care Med. 2020 Sep;48(9):1289-1295. doi: 10.1097/CCM.0000000000004447.
2
Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series.中国危重症新冠肺炎患者使用体外膜肺氧合（ECMO）治疗的预后：一项回顾性病例系列研究。
Crit Care. 2020 Apr 15;24(1):148. doi: 10.1186/s13054-020-2840-8.
3
COVID-19 pneumonia: different respiratory treatments for different phenotypes?新冠肺炎：针对不同表型采用不同的呼吸治疗方法？
Intensive Care Med. 2020 Jun;46(6):1099-1102. doi: 10.1007/s00134-020-06033-2. Epub 2020 Apr 14.
4
Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China.中国上海 2019 年冠状病毒病的体外膜肺氧合治疗。
ASAIO J. 2020 May;66(5):475-481. doi: 10.1097/MAT.0000000000001172.
5
Extracorporeal life support for 100 adult patients with severe respiratory failure.100例成人重症呼吸衰竭患者的体外生命支持
Ann Surg. 1997 Oct;226(4):544-64; discussion 565-6. doi: 10.1097/00000658-199710000-00015.